Tenaya Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Tenaya Therapeutics Total Assets Growth & History (TNYA)
Tenaya Therapeutics's total assets was $146.9M for fiscal 2025.
View full Tenaya Therapeutics company overviewTenaya Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $146.9M | $27.0M | +22.50% |
| 2024 | 2024-12-31 | $119.9M | −$50.6M | −29.66% |
| 2023 | 2023-12-31 | $170.5M | −$108.4M | −38.87% |
| 2022 | 2022-12-31 | $278.9M | −$35.2M | −11.22% |
| 2021 | 2021-12-31 | $314.2M | $166.0M | +112.06% |
| 2020 | 2020-12-31 | $148.2M | — | — |
Tenaya Therapeutics quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $93.5M | −$28.6M | −23.42% |
| Q1 2026 | 2026-03-31 | $135.1M | −$8.9M | −6.17% |
| Q4 2025 | 2025-12-31 | $146.9M | $27.0M | +22.50% |
| Q3 2025 | 2025-09-30 | $105.0M | −$35.6M | −25.32% |
| Q2 2025 | 2025-06-30 | $122.2M | −$41.0M | −25.15% |
| Q1 2025 | 2025-03-31 | $144.0M | −$40.9M | −22.15% |
| Q4 2024 | 2024-12-31 | $119.9M | −$50.6M | −29.66% |
| Q3 2024 | 2024-09-30 | $140.6M | −$52.8M | −27.31% |
| Q2 2024 | 2024-06-30 | $163.2M | −$57.6M | −26.08% |
| Q1 2024 | 2024-03-31 | $184.9M | −$60.4M | −24.64% |
| Q4 2023 | 2023-12-31 | $170.5M | −$108.4M | −38.87% |
| Q3 2023 | 2023-09-30 | $193.4M | −$32.9M | −14.54% |
| Q2 2023 | 2023-06-30 | $220.8M | −$35.2M | −13.74% |
| Q1 2023 | 2023-03-31 | $245.3M | −$36.2M | −12.84% |
| Q4 2022 | 2022-12-31 | $278.9M | −$35.2M | −11.22% |
| Q3 2022 | 2022-09-30 | $226.3M | −$105.5M | −31.79% |
| Q2 2022 | 2022-06-30 | $255.9M | $99.0M | +63.12% |
| Q1 2022 | 2022-03-31 | $281.5M | — | — |
| Q4 2021 | 2021-12-31 | $314.2M | $166.0M | +112.06% |
| Q3 2021 | 2021-09-30 | $331.8M | — | — |
| Q2 2021 | 2021-06-30 | $156.9M | — | — |
| Q4 2020 | 2020-12-31 | $148.2M | — | — |
Tenaya Therapeutics total assets trends
Over the last five fiscal years, Tenaya Therapeutics's total assets decreased from $148.2M to $146.9M, a change of −$1.2M. The latest reported quarter, Q2 2026, shows $93.5M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tenaya Therapeutics source filings ↗